These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 36835521)

  • 1. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
    Nguyen NHA; Falagan-Lotsch P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
    Wang Y; Cai R; Chen C
    Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanomaterials in the management of lung cancer.
    Guinart A; Perry HL; Wilton-Ely JDET; Tetley TD
    Emerg Top Life Sci; 2020 Dec; 4(6):627-643. PubMed ID: 33270840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein adsorption onto nanomaterials engineered for theranostic applications.
    Nienhaus K; Xue Y; Shang L; Nienhaus GU
    Nanotechnology; 2022 Apr; 33(26):. PubMed ID: 35294940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines.
    Albalawi F; Hussein MZ; Fakurazi S; Masarudin MJ
    Int J Nanomedicine; 2021; 16():161-184. PubMed ID: 33447033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms, Characterization Methods, and Utilities of Nanoparticle Biotransformation in Nanosafety Assessments.
    Cai X; Liu X; Jiang J; Gao M; Wang W; Zheng H; Xu S; Li R
    Small; 2020 Sep; 16(36):e1907663. PubMed ID: 32406193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial Nano-Bio Interfaces.
    Cai P; Zhang X; Wang M; Wu YL; Chen X
    ACS Nano; 2018 Jun; 12(6):5078-5084. PubMed ID: 29883094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
    Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
    ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review.
    Feng X; Shi Y; Zhang Y; Lei F; Ren R; Tang X
    Int J Nanomedicine; 2024; 19():1509-1538. PubMed ID: 38384321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectives.
    Lyu Q; Peng L; Hong X; Fan T; Li J; Cui Y; Zhang H; Zhao J
    Biomaterials; 2021 Mar; 270():120682. PubMed ID: 33529961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Managing Atherosclerosis via Nanomedicine.
    Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
    Small; 2018 Jan; 14(4):. PubMed ID: 29239134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-bio effects: interaction of nanomaterials with cells.
    Cheng LC; Jiang X; Wang J; Chen C; Liu RS
    Nanoscale; 2013 May; 5(9):3547-69. PubMed ID: 23532468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nanoparticles with patterned surface monolayers for nanomedicine: current perspectives.
    Pengo P; Şologan M; Pasquato L; Guida F; Pacor S; Tossi A; Stellacci F; Marson D; Boccardo S; Pricl S; Posocco P
    Eur Biophys J; 2017 Dec; 46(8):749-771. PubMed ID: 28865004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation.
    Kunzmann A; Andersson B; Thurnherr T; Krug H; Scheynius A; Fadeel B
    Biochim Biophys Acta; 2011 Mar; 1810(3):361-73. PubMed ID: 20435096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold nanoparticles application to the treatment of brain dysfunctions related to metabolic diseases: evidence from experimental studies.
    Silveira PCL; Rodrigues MS; Gelain DP; de Oliveira J
    Metab Brain Dis; 2023 Jan; 38(1):123-135. PubMed ID: 35922735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasmall silica nanoparticles in translational biomedical research: Overview and outlook.
    Singh N; Shi S; Goel S
    Adv Drug Deliv Rev; 2023 Jan; 192():114638. PubMed ID: 36462644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmable Nano-Bio Interfaces for Functional Biointegrated Devices.
    Cai P; Leow WR; Wang X; Wu YL; Chen X
    Adv Mater; 2017 Jul; 29(26):. PubMed ID: 28397302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Nano-Bio Interactions and the Corresponding Biological Responses.
    Tian X; Chong Y; Ge C
    Front Chem; 2020; 8():446. PubMed ID: 32587847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.
    Arvizo RR; Bhattacharyya S; Kudgus RA; Giri K; Bhattacharya R; Mukherjee P
    Chem Soc Rev; 2012 Apr; 41(7):2943-70. PubMed ID: 22388295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.